Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.490
+0.050 (3.47%)
At close: May 12, 2025, 4:00 PM
1.490
0.00 (0.00%)
After-hours: May 12, 2025, 4:03 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $33.35 million as of May 12, 2025. Its market cap has decreased by -86.40% in one year.
Market Cap
33.35M
Enterprise Value
-57.45M
1-Year Change
-86.40%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $33.35M, a decrease of -90.63%. That is a compound annual growth rate of -88.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 32.23M | -50.15% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |